Differential selectivity of endothelium-derived relaxing factor and nitric oxide in smooth muscle.

Por Shikano, K., Ohlstein, E. H., Berkowitz, B. A.
Publicado em 1987

Endothelin-1 does not mediate hypoxic vasoconstriction in canine isolated blood vessels: effect of BQ-123.

Por Douglas, S. A., Vickery-Clark, L. M., Ohlstein, E. H.
Publicado em 1993

The effect of diltiazem on the coronary haemodynamic and cardiac functional effects produced by intracoronary administration of endothelin-1 in the anaesthetized dog.

Por Nichols, A. J., Koster, P. F., Ohlstein, E. H.
Publicado em 1990

Pharmacological evidence for the presence of three distinct functional endothelin receptor subtypes in the rabbit lateral saphenous vein.

Por Douglas, S A, Beck, G R, Elliott, J D, Ohlstein, E H
Publicado em 1995

In vivo pharmacological characterization of the non-peptide endothelin receptor antagonist SB 209670.

Por Douglas, S A, Edwards, R M, Elliott, J D, Ohlstein, E H
Publicado em 1995

Increased endothelin excretion in rats with renal failure induced by partial nephrectomy.

Por Brooks, D. P., Contino, L. C., Storer, B., Ohlstein, E. H.
Publicado em 1991

Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus.

Por Hay, D. W., Luttmann, M. A., Beck, G., Ohlstein, E. H.
Publicado em 1996

Contractile responses to human urotensin-II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat

Por MacLean, M R, Alexander, D, Stirrat, A, Gallagher, M, Douglas, S A, Ohlstein, E H, Morecroft, I, Polland, K
Publicado em 2000

Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury.

Por Ohlstein, E H, Douglas, S A, Sung, C P, Yue, T L, Louden, C, Arleth, A, Poste, G, Ruffolo, R R, Feuerstein, G Z
Publicado em 1993

Tyr-129 is important to the peptide ligand affinity and selectivity of human endothelin type A receptor.

Por Lee, J A, Elliott, J D, Sutiphong, J A, Friesen, W J, Ohlstein, E H, Stadel, J M, Gleason, J G, Peishoff, C E
Publicado em 1994

SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist.

Por Ohlstein, E H, Nambi, P, Douglas, S A, Edwards, R M, Gellai, M, Lago, A, Leber, J D, Cousins, R D, Gao, A, Frazee, J S
Publicado em 1994

Palosuran inhibits binding to primate UT receptors in cell membranes but demonstrates differential activity in intact cells and vascular tissues

Por Behm, D J, McAtee, J J, Dodson, J W, Neeb, M J, Fries, H E, Evans, C A, Hernandez, R R, Hoffman, K D, Harrison, S M, Lai, J M, Wu, C, Aiyar, N V, Ohlstein, E H, Douglas, S A
Publicado em 2008